Engaging in collaborative research and strategic partnerships:
VAL is actively involved with collaborative research and strategic partnerships with the world’s leading research institutes. Our aim is to enhance the lives of animals and humans through developing high quality monoclonal and polyclonal antibodies for research and clinical applications.
Collaborating with academic partners is a crucial part of achieving our mission statement. Through our experience in antibody technology and our established links within the industry, we will provide help to scientists by:
- Jointly developing research antibodies for their ground-breaking research.
- Jointly developing diagnostic and therapeutic antibodies to human and animal disease.
- Helping to bring their developed products to market.
- Facilitating access to sponsored funding programmes, which require an industrial partner.
Funding schemes available to support our interaction with academic partners:
BBSRC Industrial Partner Awards and LINK
Knowledge Transfer Partnerships
Technology Strategy Board funding
To find out more about collaborating with VAL please contact us: